The effects of 5-fluorouracil and interferon-alpha on early healing of experimental intestinal anastomoses.
The continuing search for effective adjuvant therapy after resection of intestinal malignancies has prompted a growing interest in both immediate post-operative regional chemotherapy and the combination of 5-fluorouracil (5-FU) and interferon-alpha as drugs of choice. We have compared the effects of both compounds, alone and together, on early healing of intestinal anastomoses. Four groups (n = 26 each) of rats underwent resection and anastomosis of both ileum and colon: a control group and three groups receiving intraperitoneal 5-FU, interferon-alpha or both on the day of surgery and the next 2 days. Animals were killed 3 or 7 days (n = 10 each) after operation in order to measure anastomotic strength and hydroxyproline content. The remaining six animals in each group were used to study anastomotic collagen synthetic capacity at day 3. Three days after operation, ileal anastomotic bursting pressure was lowered by 37% in the 5-FU/interferon-alpha group (P = 0.0104). At day 7, anastomotic breaking strength was reduced significantly in ileum (P = 0.0221) and colon (P = 0.0054) of the 5-FU/interferon-alpha group and in colon of the interferon-alpha group (P = 0.0221). Collagen synthetic capacity was strongly suppressed by 5-FU but not by interferon-alpha. However, no differences in anastomotic hydroxyproline content were observed between groups at both days 3 and 7. Thus, post-operative use of interferon-alpha, in particular in combination with 5-FU, may be detrimental to anastomotic repair in the intestine.
de Waard
J W
JW
Department of Surgery, University Hospital Nijmegen, The Netherlands.
Wobbes
T
T
de Man
B M
BM
van der Linden
C J
CJ
Hendriks
T
T
D000714:Anastomosis, Surgical; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003094:Collagen / Q000096:biosynthesis / Q000187:drug effects; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use*; D006909:Hydroxyproline / Q000032:analysis; D016898:Interferon-alpha / Q000627:therapeutic use*; D007422:Intestines / Q000187:drug effects / Q000601:surgery*; D008297:Male; D009924:Organ Culture Techniques; D051381:Rats; D017208:Rats, Wistar; D018709:Statistics, Nonparametric; D013718:Tensile Strength; D014945:Wound Healing / Q000187:drug effects*
D016898:Interferon-alpha; D003094:Collagen; D006909:Hydroxyproline; D005472:Fluorouracil